Ledger.Open graph →
SEC Form D · filed March 3, 2025

SLAM BioTherapeutics, Inc

Offering
$10.0M
Sold
$500K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
THOUSAND OAKS, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Richard Heinick · Columbus, OHExec · DirectorDavid Vennettilli · Thousand Oaks, CADirectorTheodore Schwartz · Thousand Oaks, CADirectorSteve Potts · Thousand Oaks, CAExec · DirectorMark Hagler · Thousand Oaks, CADirectorDavid Vennettilli · Thousand Oaks, CADirectorTheodore Schwartz · Thousand Oaks, CADirectorSteve Potts · Thousand Oaks, CAExec · DirectorMark Hagler · Thousand Oaks, CADirectorRichard Heinick · Columbus, OHExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗